Stock listing
NASDAQ:IPXL Impax Laboratories Inc Stock
Follow Impax Laboratories Inc into a list and get an email when it puts out news.
Last close · NASDAQ:IPXL
$14.71 USD
Close on May 8, 2018 · No longer trades
- Lowest – highest close
- $1.00 – $51.31 USDSince Dec 22, 1997 · lowest Oct 21, 1998 · highest Apr 15, 2015
Delisted NASDAQ:IPXL no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:IPXL
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Impax Laboratories Inc on 6ix
- Decks
- 35 decks · latest Mar 1, 2018
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q4 2017 Earnings Presentation | Earnings | 23 slides | Mar 1, 2018 |
| J.P. Morgan Global Healthcare Conference 2018 | Conference | 19 slides | Jan 9, 2018 |
| Q3 2017 Earnings Presentation | Earnings | 22 slides | Nov 9, 2017 |
| Merger or Acquisition (October 2017) | Merger or acquisition | 22 slides | Oct 17, 2017 |
| Merger or Acquisition (October 2017) | Merger or acquisition | 43 slides | Oct 17, 2017 |
| Q2 2017 Earnings Presentation | Earnings | 24 slides | Aug 9, 2017 |
| Q1 2017 Earnings Presentation | Earnings | 26 slides | May 10, 2017 |
| FY2016 Earnings Presentation | Earnings | 24 slides | Mar 1, 2017 |
| 35th Annual J.P. Morgan Healthcare Conference (January 2017) | Conference | 17 slides | Jan 11, 2017 |
| Q3 2016 Earnings Presentation | Earnings | 31 slides | Nov 9, 2016 |
All 35 decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| J. Kevin Buchi Other companies: Benitec Biopharma Inc. (Director · Since at least Apr 15, 2020); Amneal Pharmaceuticals, Inc. (Director · Since at least May 4, 2018); Ampio Pharmaceuticals, Inc. (Director · Oct 13, 2021 – Jun 9, 2023 · Past); Alaunos Therapeutics, Inc. (Director · Sep 21, 2020 – Mar 4, 2021 · Past); BioSpecifics Technologies Corp (Chief Executive Officer, Director · Oct 8, 2019 – Oct 23, 2019 · Past); Dicerna Pharmaceuticals Inc (Director · Aug 13, 2018 – Dec 28, 2021 · Past); EPIRUS Biopharmaceuticals Inc (Director · Jul 15, 2014 – Jun 5, 2015 · Past); Tetralogic Pharmaceuticals Corp (President & CEO, Director · Dec 11, 2013 – Mar 26, 2015 · Past); Stemline Therapeutics Inc (Director · Jan 28, 2013 – Jun 23, 2015 · Past); Alexza Pharmaceuticals Inc (Director · Jan 2, 2013 – Jun 21, 2016 · Past); Encysive Pharmaceuticals Inc (Director · May 12, 2006 – Apr 1, 2008 · Past); Cephalon Inc (Chief Executive Officer, Director · Feb 17, 2006 – Oct 14, 2011 · Past) | Director · Nov 23, 2016 – May 4, 2018 · Past |
| Paul M. Bisaro Other companies: Myriad Genetics, Inc. (Director · Since at least Oct 31, 2022); Mallinckrodt Inc (Director · Since at least Jun 16, 2022); Zoetis Inc. (Chairman of the Board · Since at least May 1, 2015); TherapeuticsMD, Inc. (Director · Mar 20, 2020 – Sep 29, 2022 · Past); Amneal Pharmaceuticals, Inc. (Executive Chairman, Director · May 4, 2018 – May 7, 2019 · Past); Zimmer Biomet Holdings, Inc. (Director · Dec 12, 2013 – Mar 31, 2017 · Past) | President and CEO, Director · Mar 27, 2017 – May 4, 2018 · Past |
| Bryan M Reasons Other companies: Mallinckrodt Inc (EVP & CFO · Since at least Mar 18, 2019); Amneal Pharmaceuticals, Inc. (CFO · May 4, 2018 – Aug 21, 2018 · Past); Aclaris Therapeutics, Inc. (Director · Apr 20, 2018 – Jun 1, 2024 · Past); Recro Pharma Inc (Director · Mar 3, 2017 – Apr 8, 2024 · Past) | Chief Financial Officer · Apr 13, 2013 – May 4, 2018 · Past |
| Janet S. Vergis Other companies: Teva Pharmaceutical Industries Limited (Director · Since at least Jun 9, 2020); Dentsply Sirona Inc. (Director and Science and Technology Committee Chair · Since at least Sep 25, 2019); Church & Dwight Company, Inc. (Director since 2014 · Since at least May 1, 2014); Amneal Pharmaceuticals, Inc. (Director · May 4, 2018 – May 6, 2019 · Past) | Director · Oct 7, 2015 – May 4, 2018 · Past |
| Rick Bierly Other companies: OptiNose (Director · Oct 12, 2017 – Oct 12, 2017 · Past); Aclaris Therapeutics, Inc. (Director · Oct 6, 2015 – Jun 15, 2017 · Past); Medivation Inc (CFO (former) · Mar 31, 2014 – May 5, 2016 · Past) | Director · Aug 19, 2016 – May 16, 2017 · Past |
| Carole Ben-Maimon Other companies: Larimar Therapeutics, Inc. (President and CEO, Director · Since at least May 28, 2020); Teligent Inc (Director · Mar 29, 2016 – Jul 21, 2021 · Past) | President, Global Pharm. · Sep 6, 2011 – May 14, 2014 · Past |
| Robert L Burr Other companies: Amneal Pharmaceuticals, Inc. (Director · May 4, 2018 – May 6, 2019 · Past); Hudson Technologies, Inc. (Director · Sep 27, 2007 – Sep 27, 2007 · Past) | Director · Dec 31, 2006 – May 4, 2018 · Past |
| Douglas Boothe Other companies: Akorn Inc (President and CEO, Director · Jan 1, 2019 – Jan 8, 2020 · Past) | President, Generics Division · Aug 1, 2016 – May 4, 2018 · Past |
| George Fred Wilkinson Other companies: Barr Pharmaceuticals Inc (President & COO · Mar 6, 2006 – Dec 23, 2008 · Past) | Chief Executive Officer, Director · Apr 29, 2014 – Apr 29, 2016 · Past |
| Mark A Schlossberg Other companies: Cytokinetics, Incorporated (SVP - Legal & General Counsel · Jan 14, 2019 – Mar 15, 2022 · Past) | SVP and General Counsel · Feb 26, 2018 – May 4, 2018 · Past |
All 21 people
| Person | Seat |
|---|---|
| Mary K Pendergast Other companies: Oruka Therapeutics, Inc. (Director · May 24, 2006 – Feb 5, 2010 · Past) | Director · Jul 3, 2013 – May 4, 2018 · Past |
| Peter R Terreri Other companies: Amneal Pharmaceuticals, Inc. (Director · May 4, 2018 – May 4, 2020 · Past) | Director · Dec 31, 2006 – May 4, 2018 · Past |
| Allen Chao | Director · Apr 5, 2010 – May 4, 2018 · Past |
| Charles Hsiao | Director · Dec 31, 2006 – Dec 31, 2006 · Past |
| Charles V Hildenbrand | SVP, Operations · Dec 31, 2006 – May 26, 2011 · Past |
| Jeffrey Nornhold | SVP, Technical Operations · Apr 1, 2014 – May 4, 2018 · Past |
| Kim Sun Oh | Director · Dec 31, 2006 – Nov 11, 2009 · Past |
| Leslie Z Benet | Director · Dec 31, 2006 – May 4, 2018 · Past |
| Michael Markbreiter | Director · Dec 31, 2006 – Aug 28, 2015 · Past |
| Michael Nestor | President, Impax Specialty · May 20, 2010 – May 4, 2018 · Past |
| Nigel Fleming | Director · Aug 31, 2015 – Aug 31, 2015 · Past |
Log in to ask 6ix AI your own questions about Impax Laboratories Inc.